Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 392

1.

Cleavable linkers in antibody-drug conjugates.

Bargh JD, Isidro-Llobet A, Parker JS, Spring DR.

Chem Soc Rev. 2019 Jul 11. doi: 10.1039/c8cs00676h. [Epub ahead of print]

PMID:
31294429
2.

Mammalian orthoreovirus Infection is Enhanced in Cells Pre-Treated with Sodium Arsenite.

Lutz MM 4th, Worth MP, Hinchman MM, Parker JSL, Ledgerwood ED.

Viruses. 2019 Jun 18;11(6). pii: E563. doi: 10.3390/v11060563.

3.

Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series.

Picornell AC, Echavarria I, Alvarez E, López-Tarruella S, Jerez Y, Hoadley K, Parker JS, Del Monte-Millán M, Ramos-Medina R, Gayarre J, Ocaña I, Cebollero M, Massarrah T, Moreno F, García Saenz JA, Gómez Moreno H, Ballesteros A, Ruiz Borrego M, Perou CM, Martin M.

BMC Genomics. 2019 Jun 3;20(1):452. doi: 10.1186/s12864-019-5849-0.

4.

Prognostic value of B cells in cutaneous melanoma.

Selitsky SR, Mose LE, Smith CC, Chai S, Hoadley KA, Dittmer DP, Moschos SJ, Parker JS, Vincent BG.

Genome Med. 2019 May 28;11(1):36. doi: 10.1186/s13073-019-0647-5.

5.

Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.

Chera BS, Kumar S, Beaty BT, Marron D, Jefferys S, Green R, Goldman EC, Amdur R, Sheets N, Dagan R, Hayes DN, Weiss J, Grilley-Olson JE, Zanation A, Hackman T, Blumberg JM, Patel S, Weissler M, Tan XM, Parker JS, Mendenhall W, Gupta GP.

Clin Cancer Res. 2019 May 14. doi: 10.1158/1078-0432.CCR-19-0211. [Epub ahead of print]

PMID:
31088830
6.

HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade.

Prat A, Pascual T, De Angelis C, Gutierrez C, Llombart-Cussac A, Wang T, Cortés J, Rexer B, Paré L, Forero A, Wolff AC, Morales S, Adamo B, Brasó-Maristany F, Vidal M, Veeraraghavan J, Krop I, Galván P, Pavlick AC, Bermejo B, Izquierdo M, Rodrik-Outmezguine V, Reis-Filho JS, Hilsenbeck SG, Oliveira M, Dieci MV, Griguolo G, Fasani R, Nuciforo P, Parker JS, Conte P, Schiff R, Guarneri V, Osborne CK, Rimawi MF.

J Natl Cancer Inst. 2019 Apr 30. pii: djz042. doi: 10.1093/jnci/djz042. [Epub ahead of print]

PMID:
31037288
7.

Use of intraoperative anterior segment optical coherence tomography for Bowman layer transplantation.

Tong CM, Parker JS, Dockery PW, Birbal RS, Melles GRJ.

Acta Ophthalmol. 2019 Apr 23. doi: 10.1111/aos.14104. [Epub ahead of print] No abstract available.

PMID:
31016838
8.

Tracking Veterinary Students Who Aspire to Careers in Science.

McGregor DD, Fraser DR, Parker JSL.

J Vet Med Educ. 2019 Mar 28:1-6. doi: 10.3138/jvme.0118-010r1. [Epub ahead of print]

PMID:
30920950
9.

Are Descemet membrane ruptures the root cause of corneal hydrops in keratoconic eyes?

Parker JS, Birbal RS, van Dijk K, Oellerich S, Dapena I, Melles GRJ.

Am J Ophthalmol. 2019 Mar 21. pii: S0002-9394(19)30123-0. doi: 10.1016/j.ajo.2019.03.017. [Epub ahead of print]

PMID:
30905722
10.

Bacteroides Spp. Blebitis, Keratitis, and Endophthalmitis Following Uncomplicated Trabeculectomy.

Parker JS, Dockery PW, Parker JS, Crosson JN, Kilpatrick D, Samuels B.

J Glaucoma. 2019 Jul;28(7):e118-e120. doi: 10.1097/IJG.0000000000001235.

PMID:
30855413
11.

Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β-induced Serpine1.

McCann JV, Xiao L, Kim DJ, Khan OF, Kowalski PS, Anderson DG, Pecot CV, Azam SH, Parker JS, Tsai YS, Wolberg AS, Turner SD, Tatsumi K, Mackman N, Dudley AC.

J Clin Invest. 2019 Mar 11;130:1654-1670. doi: 10.1172/JCI123106. eCollection 2019 Mar 11.

12.

RNA-Sequencing of Umbilical Cord Blood to Investigate Spontaneous Preterm Birth: A Pilot Study.

Vora NL, Parker JS, Mieckowski PA, Smeester L, Fry RC, Boggess KA.

AJP Rep. 2019 Jan;9(1):e60-e66. doi: 10.1055/s-0039-1678717. Epub 2019 Mar 7.

13.

I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms.

Wong KY, Fan C, Tanioka M, Parker JS, Nobel AB, Zeng D, Lin DY, Perou CM.

Genome Biol. 2019 Mar 7;20(1):52. doi: 10.1186/s13059-019-1640-4.

14.

Separation of breast cancer and organ microenvironment transcriptomes in metastases.

Alzubi MA, Turner TH, Olex AL, Sohal SS, Tobin NP, Recio SG, Bergh J, Hatschek T, Parker JS, Sartorius CA, Perou CM, Dozmorov MG, Harrell JC.

Breast Cancer Res. 2019 Mar 6;21(1):36. doi: 10.1186/s13058-019-1123-2.

15.

Dynamic changes in lung responses after single and repeated exposures to cigarette smoke in mice.

Engle ML, Monk JN, Jania CM, Martin JR, Gomez JC, Dang H, Parker JS, Doerschuk CM.

PLoS One. 2019 Feb 28;14(2):e0212866. doi: 10.1371/journal.pone.0212866. eCollection 2019.

16.

Corneal ulceration associated with Nivolumab use.

Parker JS, Feagin W, Wang C, Heersink M, Parker JS.

Am J Ophthalmol Case Rep. 2019 Feb 7;14:26-27. doi: 10.1016/j.ajoc.2019.01.013. eCollection 2019 Jun.

17.

Correction: A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody-drug conjugates.

Walsh SJ, Omarjee S, Galloway WRJD, Kwan TT, Sore HF, Parker JS, Hyvönen M, Carroll JS, Spring DR.

Chem Sci. 2018 Dec 13;10(2):633-634. doi: 10.1039/c8sc90248h. eCollection 2019 Jan 14.

18.

A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody-drug conjugates.

Walsh SJ, Omarjee S, Galloway WRJD, Kwan TT, Sore HF, Parker JS, Hyvönen M, Carroll JS, Spring DR.

Chem Sci. 2018 Nov 9;10(3):694-700. doi: 10.1039/c8sc04645j. eCollection 2019 Jan 21. Erratum in: Chem Sci. 2018 Dec 13;10(2):633-634.

19.

Cells exhibiting strong p16 INK4a promoter activation in vivo display features of senescence.

Liu JY, Souroullas GP, Diekman BO, Krishnamurthy J, Hall BM, Sorrentino JA, Parker JS, Sessions GA, Gudkov AV, Sharpless NE.

Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2603-2611. doi: 10.1073/pnas.1818313116. Epub 2019 Jan 25.

20.

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.

Zhao X, Little P, Hoyle AP, Pegna GJ, Hayward MC, Ivanova A, Parker JS, Marron DL, Soloway MG, Jo H, Salazar AH, Papakonstantinou MP, Bouchard DM, Jefferys SR, Hoadley KA, Ollila DW, Frank JS, Thomas NE, Googe PB, Ezzell AJ, Collichio FA, Lee CB, Earp HS, Sharpless NE, Hugo W, Wilmott JS, Quek C, Waddell N, Johansson PA, Thompson JF, Hayward NK, Mann GJ, Lo RS, Johnson DB, Scolyer RA, Hayes DN, Moschos SJ.

Front Oncol. 2019 Jan 4;8:584. doi: 10.3389/fonc.2018.00584. eCollection 2018.

Supplemental Content

Loading ...
Support Center